Bladder Cancer News

IBCN 2017: Bladder Cancer Models - UroToday - UroToday



IBCN 2017: Bladder Cancer Models - UroToday 
UroToday
IBCN 2017, bladder cancer, Mullenders, Joshua Meeks, Stephen B. Williams and Ashish M. Kamat.

and more » 


IBCN 2017: Keynote Lecture - Molecular Pathology in Bladder Cancer - UroToday



IBCN 2017: Keynote Lecture - Molecular Pathology in Bladder Cancer 
UroToday
Bladder cancer historically had two pathways of tumor initiation which include low grade superficial papillary urothelial carcinoma and carcinoma in situ which may lead to development of muscle-invasive disease. Molecular characterization of these ...

 


The Optimal Treatment of Muscle Invasive Urothelial Bladder ... - UroToday



The Optimal Treatment of Muscle Invasive Urothelial Bladder ... 
UroToday
SIU 2017, Peter Black, Makarand Khochikar, bladder cancer, Thenappan Chandrasekar,

and more » 


IBCN 2017: Bladder Cancer Pipeline- TARIS Technology Update in Urothelial Carcinoma - UroToday



IBCN 2017: Bladder Cancer Pipeline- TARIS Technology Update in Urothelial Carcinoma 
UroToday
... Branch, Galveston, TX. and Ashish M. Kamat, M.D. Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX., at the International Bladder Cancer Network - October 21, 2017- Lisbon, Portugal.

 


SIU 2017: Controversies in Urology--Bladder Cancer: Old is Gold! - UroToday



SIU 2017: Controversies in Urology--Bladder Cancer: Old is Gold! 
UroToday
SIU 2017: Controversies in Urology--Bladder Cancer: Old is Gold! Published 23 October 2017; Lisbon, Portugal (UroToday.com) Dr. Risk presented his support for the old traditional white light cystoscopy. Dr. Risk began with stating that there is a need ...

 


Experimental 'nano-chemo' particle to treat bladder cancer ... - Science Daily



European Pharmaceutical Review
 
Experimental 'nano-chemo' particle to treat bladder cancer ... 
Science Daily
Working with mice and rats, researchers have developed a way to successfully deliver nano-sized, platinum-based chemotherapy drugs to treat a form of ...
Experimental nano-chemo particle to treat bladder cancer European Pharmaceutical Review

all 4 news articles » 


NICE shoots down Opdivo again, this time in bladder cancer ... - FiercePharma



FiercePharma
 
NICE shoots down Opdivo again, this time in bladder cancer ... 
FiercePharma
Here's a sentence Bristol-Myers Squibb should be used to by now: England's cost watchdogs have decided not to back routine NHS coverage of ...

and more » 


Australia's high rates of bladder cancer deaths show why blood in urine should always be investigated - The Conversation AU



The Conversation AU
 
Australia's high rates of bladder cancer deaths show why blood in urine should always be investigated 
The Conversation AU
... (compared to 0.2 for breast and colon cancer and 0.8 for lung cancer). While the relative survival (survival compared to a healthy individual of similar age) for most other cancers has improved in Australia, for bladder cancer this has decreased ...

 


Multidisciplinary Approach Vital in Bladder Cancer - Curetoday.com



Curetoday.com
 
Multidisciplinary Approach Vital in Bladder Cancer 
Curetoday.com
It's clear that there are also patients with non-muscle invasive bladder cancer who have a very high risk of dying. Therefore, in the future, the medical oncologists are going to be getting involved in this setting for two reasons: Firstly, the current ...

 


SIU 2017: Translational Observations from Mutation Profiling of Muscle Invasive Bladder Cancer - UroToday



SIU 2017: Translational Observations from Mutation Profiling of Muscle Invasive Bladder Cancer 
UroToday
Published 22 October 2017; Lisbon, Portugal (UroToday.com) Dr. Lerner provided a very informative update on the current status of translational observations from mutational profiling of muscle invasive bladder cancer (MIBC). There has been significant ...